Pediatric Nephrology

, Volume 28, Issue 7, pp 1001–1009

Indications for use and safety of rituximab in childhood renal diseases


DOI: 10.1007/s00467-012-2260-3

Cite this article as:
Tullus, K. & Marks, S.D. Pediatr Nephrol (2013) 28: 1001. doi:10.1007/s00467-012-2260-3


Rituximab was initially developed for the treatment of patients with B cell lymphoma but has during the last decade proven to be quite effective in treating a range of kidney diseases including lupus nephritis, nephrotic syndrome, and also in different situations before and after a renal transplant. We will here review the scientific basis for the use of rituximab in children with renal diseases and give recommendations both regarding its clinical use and need for further research.


RituximabSLENephrotic syndromeRenal transplant

Copyright information

© IPNA 2012

Authors and Affiliations

  1. 1.Department of Paediatric NephrologyGreat Ormond Street Hospital for Children NHS TrustLondonUK